Health Matters December 20: Right now most people who use continuous glucose monitors have Type 1 diabetes. But University of Alberta researchers suspect those with Type 2 could also benefit from the devices. They're hoping their study will help improve insurance coverage for the technology. Su-Ling Goh reports.